Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy
WikiImages / Pixabay

Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy

According to a story from news-medical.net, an international research team affiliated with the UK Medical Research Council, Indiana University School of Medicine, and the University of Kansas have released a…

Continue Reading Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy

Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year

According to a publication from Reuters, based on early clinical data, American biotechnology company BioMarin Pharmaceuticals believes that a single injection of its experimental hemophilia A drug could relieve symptoms…

Continue Reading Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year
4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms
source: pixabay.com

4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms

  Functional neurological disorder is a conversion disorder. This type of complex disorder is often thought to be linked with psychological symptoms, serious stress, or mental distress. With functional neurological…

Continue Reading 4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms
New Discoveries Reveal Further Connections Between the Gut Microbiome, Human Health, and Rare Diseases
geralt / Pixabay

New Discoveries Reveal Further Connections Between the Gut Microbiome, Human Health, and Rare Diseases

According to a story from bioengineer.org, a team of researchers associated with Oregon State University are making further headway in understanding the connection between our health and the bacteria that…

Continue Reading New Discoveries Reveal Further Connections Between the Gut Microbiome, Human Health, and Rare Diseases
First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease
Free-Photos / Pixabay

First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

Do you have ADPKD? If you or someone you know has ADPKD, email us at [email protected]. We'd love to hear from you about your experience! According to a story from…

Continue Reading First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

Phase 2 Clinical Trial for Microvillus Inclusion Disease Approved to Begin in Turkey

MVID Microvillus inclusion disease (MVID) is a rare, gastrointestinal disease which can cause impaired development in children. It is characterized by severe diarrhea which leads to dehydration and malnutrition. MVID…

Continue Reading Phase 2 Clinical Trial for Microvillus Inclusion Disease Approved to Begin in Turkey

Phase 1/2 Trial for an Experimental Phenylketonuria Gene Therapy Has Begun Enrollment

According to a story from globenewswire.com, the genetic medicines company Homology Medicines, Inc. has recently announced that it has opened enrollment for its phase 1/2 clinical trial. This clinical trial…

Continue Reading Phase 1/2 Trial for an Experimental Phenylketonuria Gene Therapy Has Begun Enrollment
ICYMI: First Patient is Dosed in Phase 2 Friedreich’s Ataxia Trial
HeungSoon / Pixabay

ICYMI: First Patient is Dosed in Phase 2 Friedreich’s Ataxia Trial

According to a story from Ysios Capital, the biotechnology company Minoryx Therapeutics recently announced that the first patient has been dosed in the company's phase 2 clinical trial. This trial…

Continue Reading ICYMI: First Patient is Dosed in Phase 2 Friedreich’s Ataxia Trial
Immunotherapy Elicits Positive Response in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients
source: pixabay.com

Immunotherapy Elicits Positive Response in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients

According to a story from mdmag.com, a recent study that was presented at the 2019 meeting of the American Society of Clinical Oncology has demonstrated the potential of a two…

Continue Reading Immunotherapy Elicits Positive Response in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients

Novel Finding Could Lead to the Development of a “Resistance-Proof” Antiviral Drug

A recent study published in PLOS Biology has shown a promising new vulnerability within human viruses which could lead to the development of a new antiviral drug. This study was…

Continue Reading Novel Finding Could Lead to the Development of a “Resistance-Proof” Antiviral Drug

ICYMI: Gene Therapy That Could Make β-Thalassemia Patients Transfusion Independent Receives Marketing Authorization in EU

Transfusion-Dependent β-Thalassemia (TDT) Transfusion-dependent β-thalassemia (TDT) is a rare disease that is caused by a mutated β-globin gene. This mutation causes the amount of hemoglobin in the body to be…

Continue Reading ICYMI: Gene Therapy That Could Make β-Thalassemia Patients Transfusion Independent Receives Marketing Authorization in EU

Extremely Positive Results Announced from Interim Analysis of Phase 2 Clinical Trial for Hemochromatosis

Hereditary Hemochromatosis Hereditary hemochromatosis (HH) is a rare disease caused by hepcidin deficiency or hepcidin insensitivity. Hepcidin naturally regulates iron absorption/distribution in the body. Without hepcidin, HH patients suffer from…

Continue Reading Extremely Positive Results Announced from Interim Analysis of Phase 2 Clinical Trial for Hemochromatosis

Very First Patient Dosed with Investigational Therapy for Friedreich’s Ataxia in Phase 2 Clinical Trial

Friedreich's Ataxia Friedreich's ataxia (FRDA) is a rare disease which is caused by a frataxin deficiency. This deficiency results in the degeneration of nerves within the spinal cord. This nerve…

Continue Reading Very First Patient Dosed with Investigational Therapy for Friedreich’s Ataxia in Phase 2 Clinical Trial